Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
6,878,758
-
Share change
-
+6,877,723
-
Total reported value
-
$334,861,444
-
Price per share
-
$48.44
-
Number of holders
-
79
-
Value change
-
+$334,810,524
-
Number of buys
-
78
Institutional Holders of Inari Medical, Inc. - Common Stock, par value $0.001 per share (NARI) as of Q2 2020
As of 30 Jun 2020,
Inari Medical, Inc. - Common Stock, par value $0.001 per share (NARI) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,878,758 shares.
The largest 10 holders included
ALLIANCEBERNSTEIN L.P., PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Capital International Investors, BROWN ADVISORY INC, FRANKLIN RESOURCES INC, ADAGE CAPITAL PARTNERS GP, L.L.C., VR Adviser, LLC, and GILDER GAGNON HOWE & CO LLC.
This page lists
79
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.